NASDAQ:NEUP | Income Statement | Neuphoria Therapeutics Inc.

Complete source-backed income-statement history.

Available history
2023-06-30 to 2026-03-31
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-03-31$1.21M-$1.21M$671,793.00-$539,856.00-$34,793.00-$505,063.00-$0.09-$0.095,411,2445,411,244
2025-12-31$697,723.00$4.06M-$4.06M$5.89M$1.83M-$34,794.00$1.86M$0.41-$0.774,536,2354,536,235
2025-09-30$3.79M$5.65M-$5.65M-$4.29M-$9.94M-$34,793.00-$9.91M-$4.41-$4.412,246,0662,246,066
2025-06-30-$13,267.00$3.75M$5.82M-$5.84M-$3.32M-$9.15M-$266,602.00-$8.88M-$5.79-$5.7992,83392,833
2025-03-31$15M$1.62M$3.02M$11.98M-$796,218.00$11.18M-$81,186.00$11.26M$6.55$6.551,719,0731,719,073
2024-12-31$662,715.00$1.74M$4.37M-$3.7M$1.77M-$1.93M$11,609.00-$1.94M-$1.23-$1.791,575,2441,575,244
2024-09-30$1.9M$3.57M-$3.57M$2.63M-$936,974.00-$132,187.00-$804,787.00-$0.62-$0.621,300,0651,300,065
2024-06-30$3.1M$5.48M-$5.48M$2.76M-$2.72M-$34,116.00-$2.69M-$3.42-$3.42-10,206-10,206
2024-03-31$1.2M$2.39M-$2.39M-$367,734.00-$2.76M$16,383.00-$2.78M-$2.83-$2.83981,040981,040
2023-12-31$2.03M$4.55M-$4.55M-$36,356.00-$4.59M-$34,794.00-$4.55M-$5.31-$5.31857,264857,264
2023-09-30$3.09M$5.47M-$5.47M-$39,754.00-$5.51M-$34,793.00-$5.47M$0.00$0.001,495,995,0351,495,995,035

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-06-30$15.65M$9.01M$16.78M-$1.13M$291,093.00-$837,998.00-$468,366.00-$369,632.00-$0.23-$0.231,622,9241,622,924
2024-06-30$9.42M$17.89M-$17.89M$2.31M-$15.58M-$87,320.00-$15.49M-$18.62-$18.62832,225832,225
2023-06-30$13.07M$21.98M-$21.98M$462,125.00-$21.52M-$139,174.00-$21.38M-$0.02-$0.021,468,735,4241,468,735,424